Meningitis can have a devastating effect, with possible brain damage and the loss of limbs. Until recently there hasn't been a way of preventing Meningitis B. But experts in Southampton are trialling a new vaccine - before the government decides if it will be used here in the UK.
Around 1870 people contract the infection each year. Many of them children under five or babies. And one in 10 survivors have major physical or neurological disabilities.
The experts at Southampton are still looking for volunteers. So if you're aged between 10 to 18 years of age and are interested you can contact the Meningitis Trial team at the Southampton Research Facility on 023 81204989. Or email: Danny.firstname.lastname@example.org
Doctors based at Southampton's university hospitals are trialling a new vaccine that could offer children across the UK “broad protection” against meningitis B.
The study, being conducted at the NIHR Wellcome Trust Clinical Research Facility at Southampton General Hospital, will investigate the effectiveness of the vaccine in 50 children and young people between the ages of 10 and 18.
This strain of meningitis, known as serogroup B, is a highly aggressive bacterial infection that causes swelling of the brain and spinal cord and can lead to brain damage or blood poisoning.
Professor Saul Faust is a specialist in children's immunology and infectious diseases at Southampton General Hospital and has worked on the vaccine.
He said, “This is an extremely exciting study of a vaccine that could prove to provide broad protection against meningitis B, which is the major cause of brain inflammation and blood poisoning in the UK."
Meningitis can cause devastation for families. And that's why a campaign to get a vaccine for all children in the UK is gaining support. Eleanor Coneybeare, who's three and from Berkshire, was struck down with the disease when she was a baby - Divya Kohli reports.